European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. However, it is clear that changes are likely to have meaningful impacts for biopharma players if adopted.

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

European Pharmaceutical Review

AUGUST 24, 2023

This strategy shift did not occur overnight, but evolved in response to the changing biopharma landscape. Even among the leaders of the biopharma sector, few companies have a significant presence across these platforms, Baral highlighted. The post Divest to invest: the new normal in biopharma?

Biopharma 98

Biopharma Pharmaceutical Pharma Medical 98

pharmaphorum

JANUARY 24, 2023

A just-published report from the Medicines Manufacturing Industry Partnership (MMIP) – set up by the UK government and biopharma industry in 2014 to drive growth in the category – says the sector has the potential to be a driver for the UK economy in the next decade. Established trends are unfortunately firmly in the wrong direction.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

PM360

OCTOBER 3, 2023

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc.

Education 122

Education Marketing Media Pharmaceutical 122

pharmaphorum

JANUARY 3, 2023

Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member and biopharma industry veteran Iain Ross appointed as executive chairman with a remit to revamp the business. Isted joined ReNeuron as chief financial officer in 2021, before stepping up to the top job for just a few months.

Biopharma 59

Biopharma Pharma Leads Management 59

Clarivate

NOVEMBER 10, 2022

The evidence standards that a COA must meet to support key clinical trial endpoints have become increasingly stringent in recent decades, following the introduction of the United States Food and Drug Administration (FDA) Patient Reported Outcomes (PRO) draft guidance in 2006, followed by the full guidance in 2009.

Patients 52

Patients Food and Drug Administration FDA Safety 52

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Braun Medical, Inc.

Marketing 52

Marketing Education Healthcare Healthcare 52